Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial

[1]  G. Leroux-Roels,et al.  Immunogenicity and safety of a novel monovalent high-dose inactivated poliovirus type 2 vaccine in infants: a comparative, observer-blind, randomised, controlled trial. , 2016, The Lancet. Infectious diseases.

[2]  R. Sutter,et al.  Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial , 2015, The Lancet.

[3]  S. Self,et al.  Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study. , 2015, The Lancet. Infectious diseases.

[4]  S. Chu,et al.  Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trial. , 2015, The Lancet. Infectious diseases.

[5]  A. Zaidi,et al.  Monovalent type-1 oral poliovirus vaccine given at short intervals in Pakistan: a randomised controlled, four-arm, open-label, non-inferiority trial. , 2015, The Lancet. Infectious diseases.

[6]  Walter A Orenstein,et al.  Polio vaccination: past, present and future. , 2015, Future microbiology.

[7]  E. Guccione,et al.  Trained immunity in newborn infants of HBV-infected mothers , 2015, Nature Communications.

[8]  R. Sutter,et al.  Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. , 2014, The Journal of infectious diseases.

[9]  N. Grassly.  Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysis , 2014, The Journal of infectious diseases.

[10]  G. Kang,et al.  Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial , 2014, The Lancet.

[11]  N. Grassly,et al.  Efficacy of inactivated poliovirus vaccine in India , 2014, Science.

[12]  G. Kang,et al.  Eff ect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine : an open-label , randomised controlled trial , 2014 .

[13]  M. Netea,et al.  Trained immunity: a memory for innate host defense. , 2011, Cell host & microbe.

[14]  S. Plotkin.  Correlates of Vaccine-Induced Immunity , 2008 .

[15]  T. Kimman,et al.  Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. , 1999, Journal of immunology.

[16]  D. Henderson,et al.  Disease eradication and control in the Americas. , 1993, Biologicals : journal of the International Association of Biological Standardization.

[17]  P. Wright,et al.  Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. , 1991, Reviews of infectious diseases.

[18]  T. John,et al.  Efficacy of inactivated poliovirus vaccine in India. , 1983, Bulletin of the World Health Organization.

[19]  W. Kröger,et al.  Recommendations , 1915, Nature.

[20]  J. Melnick,et al.  Heterotypic antibody response after feeding of monovalent attenuated live poliovaccine. , 1962, The New England journal of medicine.

[21]  A. Sabin.  TRANSITORY APPEARANCE OF TYPE 2 NEUTRALIZING ANTIBODY IN PATIENTS INFECTED WITH TYPE 1 POLIOMYELITIS VIRUS , 1952, The Journal of experimental medicine.